- Filed
- Oct 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Oct 8, 2025 | 11.76M sh |
| Operating Cash Flow | Q2 2026 · Aug 31, 2025 | $464.3K |
| Operating Cash Flow restated | Q2 2026 · Aug 31, 2024 | $654.61K |
| Cash And Equivalents | Q2 2026 · Aug 31, 2025 | $2.25M |
| Cash And Equivalents | Q2 2026 · Feb 28, 2025 | $2.77M |
| Cash And Equivalents | Q2 2026 · Aug 31, 2024 | $2.76M |
| Cash And Equivalents | Q2 2026 · Feb 29, 2024 | $2.81M |
| Stockholders Equity | Q2 2026 · Aug 31, 2025 | $4.84M |
| Stockholders Equity | Q2 2026 · May 31, 2025 | $4.37M |
| Stockholders Equity | Q2 2026 · Feb 28, 2025 | $4.27M |
| Stockholders Equity | Q2 2026 · Aug 31, 2024 | $2.53M |
| Stockholders Equity | Q2 2026 · May 31, 2024 | $2.25M |
| Stockholders Equity | Q2 2026 · Feb 29, 2024 | $2.17M |
| Current Liabilities | Q2 2026 · Aug 31, 2025 | $1.53M |
| Current Liabilities | Q2 2026 · Feb 28, 2025 | $1.51M |
| Total Liabilities | Q2 2026 · Aug 31, 2025 | $1.53M |
| Total Liabilities | Q2 2026 · Feb 28, 2025 | $2.54M |
| Current Assets | Q2 2026 · Aug 31, 2025 | $5.98M |
| Current Assets | Q2 2026 · Feb 28, 2025 | $6.42M |
| Total Assets | Q2 2026 · Aug 31, 2025 | $6.37M |
| Total Assets | Q2 2026 · Feb 28, 2025 | $6.81M |
| Eps Diluted | Q2 2026 · Aug 31, 2025 | $0.03 |
| Eps Diluted | Q2 2026 · Aug 31, 2025 | $0.04 |
| Eps Diluted | Q2 2026 · Aug 31, 2024 | $0.02 |
| Eps Diluted | Q2 2026 · Aug 31, 2024 | $0.03 |
| Eps Basic | Q2 2026 · Aug 31, 2025 | $0.03 |
| Eps Basic | Q2 2026 · Aug 31, 2025 | $0.04 |
| Eps Basic | Q2 2026 · Aug 31, 2024 | $0.02 |
| Eps Basic | Q2 2026 · Aug 31, 2024 | $0.03 |
| Sga Expense | Q2 2026 · Aug 31, 2025 | $725.47K |
| Sga Expense | Q2 2026 · Aug 31, 2025 | $1.3M |
| Sga Expense | Q2 2026 · Aug 31, 2024 | $353.81K |
| Sga Expense | Q2 2026 · Aug 31, 2024 | $631.01K |
| Rd Expense | Q2 2026 · Aug 31, 2025 | $66.24K |
| Rd Expense | Q2 2026 · Aug 31, 2025 | $115.25K |
| Rd Expense | Q2 2026 · Aug 31, 2024 | $1.89K |
| Rd Expense | Q2 2026 · Aug 31, 2024 | $16.87K |
| Net Income | Q2 2026 · Aug 31, 2025 | $346.57K |
| Net Income | Q2 2026 · Aug 31, 2025 | $460.35K |
| Net Income | Q2 2026 · Aug 31, 2024 | $284.75K |
| Net Income | Q2 2026 · Aug 31, 2024 | $371.95K |
| Operating Income | Q2 2026 · Aug 31, 2025 | $528.57K |
| Operating Income | Q2 2026 · Aug 31, 2025 | $806.02K |
| Operating Income | Q2 2026 · Aug 31, 2024 | $435.75K |
| Operating Income | Q2 2026 · Aug 31, 2024 | $704.92K |
| Gross Profit | Q2 2026 · Aug 31, 2025 | $2M |
| Gross Profit | Q2 2026 · Aug 31, 2025 | $2.93M |
| Gross Profit | Q2 2026 · Aug 31, 2024 | $833.41K |
| Gross Profit | Q2 2026 · Aug 31, 2024 | $1.43M |
| Cost Of Revenue | Q2 2026 · Aug 31, 2025 | $1.23M |
| Cost Of Revenue | Q2 2026 · Aug 31, 2025 | $2.44M |
| Cost Of Revenue | Q2 2026 · Aug 31, 2024 | $970.61K |
| Cost Of Revenue | Q2 2026 · Aug 31, 2024 | $1.62M |
| Revenue | Q2 2026 · Aug 31, 2025 | $3.24M |
| Revenue | Q2 2026 · Aug 31, 2025 | $5.37M |
| Revenue | Q2 2026 · Aug 31, 2024 | $1.8M |
| Revenue | Q2 2026 · Aug 31, 2024 | $3.06M |
| Capex restated | Q2 2026 · Aug 31, 2024 | $17.73K |